Caution for interstitial lung disease as a cause of CA 15-3 rise in advanced breast cancer patients treated with everolimus

Annelieke E.C.A.B. Willemsen, Jan C. Grutters, Winald R. Gerritsen, Jolien Tol, Carla M.L. Van Herpen

Research output: Contribution to journalLetterpeer-review

Fingerprint

Dive into the research topics of 'Caution for interstitial lung disease as a cause of CA 15-3 rise in advanced breast cancer patients treated with everolimus'. Together they form a unique fingerprint.